Keyword

BASFI

Description: The Bath Ankylosing Spondylitis Functional Index is a patient-reported measure of functional limitations associated with ankylosing spondylitis.

Primary topic: Spondyloarthritis Studies and Treatments (92%)

Wikidata ID: wiki/Q4834653

OpenAlex ID: keywords/basfi

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis functional index

2001 · CRC Press eBooks · 1,833

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

1994 · A Calin, S Garrett, et al. · PubMed · 1,833

Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)

2005 · Désirée van der Heijde, Ben Dijkmans, et al. · Arthritis & Rheumatism · 860

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

2013 · R Landewé, J Braun, et al. · Annals of the Rheumatic Diseases · 470

PDF

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis

2004 · M Rudwaleit, J Listing, et al. · Annals of the Rheumatic Diseases · 439

PDF

Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS‐G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ‐S)

2011 · Jane Zochling · Arthritis Care & Research · 349

The Bath Ankylosing Spondylitis Patient Global Score (bas-g)

1996 · S. D. JONES, A. STEINER, et al. · Lara D. Veeken · 314

Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: A clinical and magnetic resonance imaging study

2001 · Helena Marzo-Ortega, Dennis McGonagle, et al. · Arthritis & Rheumatism · 299

Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine

2008 · R Landewé, M Dougados, et al. · Annals of the Rheumatic Diseases · 276

Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort

2006 · Wonuk Lee, John D Reveille, et al. · Annals of the Rheumatic Diseases · 273

A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity

2004 · Yesim Akkoc, Altinay Goksel Karatepe, et al. · Rheumatology International · 251

TNF-alpha inhibitors for ankylosing spondylitis

2015 · Lara J Maxwell, Jane Zochling, et al. · Cochrane Database of Systematic Reviews · 243

PDF

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: A six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug

2001 · Maxime Dougados, Jehan-Michel B�hier, et al. · Arthritis & Rheumatism · 241

Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: Results of a fifty‐two–week, randomized, controlled study

2005 · Désirée van der Heijde, Herbert S. B. Baraf, et al. · Arthritis & Rheumatism · 230

Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry

2010 · Bente Glintborg, Mikkel Østergaard, et al. · Annals of the Rheumatic Diseases · 221

Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis

2014 · Johanna Callhoff, Joachim Sieper, et al. · Annals of the Rheumatic Diseases · 210

Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery

2009 · Bert Vander Cruyssen, Elisa Muñoz-Gomariz, et al. · Lara D. Veeken · 207

PDF

Predicting the outcome of ankylosing spondylitis therapy

2011 · Nathan Vastesaeger, Désirée van der Heijde, et al. · Annals of the Rheumatic Diseases · 190

PDF

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial

2008 · D van der Heijde, M H Schiff, et al. · Annals of the Rheumatic Diseases · 188

PDF

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation

2007 · C McLeod, A Bagust, et al. · Health Technology Assessment · 188

PDF

Disease and psychological status in ankylosing spondylitis

2006 · J. Martindale, J. Smith, et al. · Lara D. Veeken · 174

PDF

Assessment of fatigue in patients with ankylosing spondylitis: A psychometric analysis

2002 · Astrid van Tubergen, Jolanda Coenen, et al. · Arthritis Care & Research · 163

The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis

2018 · Sizheng Zhao, Daniel Thong, et al. · Arthritis Research & Therapy · 160

PDF

Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis

2007 · Walter P. Maksymowych, Rhonda Richardson, et al. · Arthritis Care & Research · 151

Comparison of serum IL-1β, sIL-2R, IL-6, and TNF-α levels with disease activity parameters in ankylosing spondylitis

2006 · A. Bal, E. Unlu, et al. · Clinical Rheumatology · 150

Works count: 2,174

Citation count: 29,000